dual gip glp 1 receptor agonists GIPR/GLP-1R agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Efficacy and safety of LY3298176,

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index

These medications help people lose weight and manage blood sugar

Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S

95% CI 0.310.50), MACEs (aHR 0.66

THURSDAY, Dec